The effect of intravenous dexamethasone injection on pain after cesarean section.
Conditions
Interventions
Intervention 1: Control group: Patients in the intervention group will receive IV dexamethasone 8 mg (2 mL) after clamping the umbilical cord. Intervention 2: Control group: After clamping the umbilic
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Gestational age> = 37 weeks Age over 18 years and no history of specific disease Uncomplicated pregnancy Elective cesarean section (breech, meconium, macrosome, ripit 2) Absence of previous laparotomy incision except cesarean section
Exclusion criteria
Exclusion criteria: contraindications to spinal anesthesia allergy to study medications uncontrolled hypertension uncontrolled diabetes mellitus glaucoma IV drug abuse , chronic pain or long-term opioid use steroid medication within the week prior to cesarean delivery subjects with psychiatric illness that would prohibit informed consent or comprehension of the study questions repeat 3 cesarean section or more than two laparotomies chorioamnionitis Intra-abdominal adhesions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effect of intravenous dexamethasone on pain after cesarean section. Timepoint: 6,12,18,24 hour after surgery. Method of measurement: Both baseline preoperative and postoperative pain scores at rest and movement will be assessed using a numerical rating scale (NRS) ( 0 means “no pain” and 10 means “the worst possible pain”). Pain at rest will be assessed with the patient lying supine and pain with movement will be assessed when moving from the supine to an upright sitting position.;Nausea. Timepoint: 6,12,18,24 hour after surgery. Method of measurement: Patients will be asked to rate the severity of postoperative nausea using an 11-point numerical rating scale (NRS) from 0 to 10 (0: “no nausea” to 10: “worst nausea possible”). The number of vomiting episodes, if any during the 24-h study period, will be documented.;Pruritus. Timepoint: 6,12,18,24 hour after surgery. Method of measurement: Pruritus will be assessed using an 11-point NRS (0: “no pruritus” to 10: “worst pruritus possible”). | — |
Secondary
| Measure | Time frame |
|---|---|
| Headache. Timepoint: 6,12,18,24 hour after surgery. Method of measurement: Patients will be asked to rate the severity of postoperative headache using an 11-point numerical rating scale (NRS) from 0 to 10 (0: “no headache” to 10: “worst headache possible”). The number of headache episodes, if any during the 24-h study period, will be documented. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyedeh Firouzeh Aghanejad
Qazvin University of Medical Sciences
Outcome results
None listed